Active Ingredient History
Rebamipide, an amino acid derivative of 2-(1H)-quinolinone, is used for mucosal protection, healing of gastroduodenal ulcers, and treatment of gastritis. It works by enhancing mucosal defense, scavenging free radicals, and temporarily activating genes encoding cyclooxygenase-2. Wikipedia
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Organization | Org Type | FDA approvals | Clinical Trials involvement | Org ID | Force Sort |
---|
Anti-Inflammatory Agents (Phase 4)
Arthritis, Rheumatoid (Phase 4)
Colitis, Ulcerative (Phase 2)
Corneal Diseases (Phase 2)
Dry Eye Syndromes (Phase 4)
Dyspepsia (Phase 4)
Enteritis (Phase 4)
Gastritis (Phase 4)
Gastroesophageal Reflux (Phase 4)
Head and Neck Neoplasms (Phase 2)
Healthy Volunteers (Phase 1)
Hypercholesterolemia (Phase 3)
Intestinal Neoplasms (Phase 1)
Keratoconjunctivitis Sicca (Phase 3)
Musculoskeletal Diseases (Phase 4)
Osteoarthritis (Phase 4)
Pancreatitis (Phase 3)
Peptic Ulcer (Phase 2/Phase 3)
Sjogren's Syndrome (Phase 4)
Spondylitis, Ankylosing (Phase 4)
Stomach Diseases (Phase 4)
Stomach Ulcer (Phase 4)
Xerostomia (Phase 2)
Trial | Phase | Start Date | Organizations | Indications |
---|
Feedback
Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).
Report issue